GEODE CAPITAL MANAGEMENT, LLC - TREVI THERAPEUTICS INC ownership

TREVI THERAPEUTICS INC's ticker is TRVI and the CUSIP is 89532M101. A total of 33 filers reported holding TREVI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of TREVI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,717,276
-7.7%
787,640
+1.1%
0.00%
Q2 2023$1,861,382
+305.2%
778,821
+213.7%
0.00%
Q1 2023$459,342
+112483.8%
248,293
+17.4%
0.00%
Q4 2022$408
-99.9%
211,547
+5.7%
0.00%
Q3 2022$308,000
-43.8%
200,221
+2.6%
0.00%
Q2 2022$548,000
+242.5%
195,146
+168.3%
0.00%
Q1 2022$160,000
+321.1%
72,744
+48.2%
0.00%
Q4 2021$38,000
-43.3%
49,0770.0%0.00%
Q3 2021$67,000
-39.1%
49,0770.0%0.00%
Q2 2021$110,000
-17.3%
49,0770.0%0.00%
Q1 2021$133,000
+12.7%
49,0770.0%0.00%
Q4 2020$118,000
-40.1%
49,0770.0%0.00%
Q3 2020$197,000
-28.4%
49,077
+17.1%
0.00%
Q2 2020$275,000
+100.7%
41,9130.0%0.00%
Q1 2020$137,000
-55.8%
41,913
-49.5%
0.00%
Q4 2019$310,000
+66.7%
82,964
+100.0%
0.00%
Q3 2019$186,000
-40.2%
41,4820.0%0.00%
Q2 2019$311,00041,4820.00%
Other shareholders
TREVI THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
NEA Management Company, LLC 11,370,376$24,787,4201.91%
Fairmount Funds Management LLC 5,163,287$11,255,9661.35%
Opaleye Management Inc. 1,705,900$3,718,8621.21%
Frazier Life Sciences Management, L.P. 6,881,090$15,000,7761.00%
VR Adviser, LLC 3,422,397$7,460,8250.78%
SILVERARC CAPITAL MANAGEMENT, LLC 927,415$2,021,7650.61%
Rubric Capital Management LP 5,684,420$12,392,0360.46%
Tejara Capital Ltd 180,227$392,8950.22%
PFS Partners, LLC 100,000$218,0000.19%
WealthTrust Axiom LLC 93,500$203,8300.07%
View complete list of TREVI THERAPEUTICS INC shareholders